ZUBSOLV (buprenorphine HCl/naloxone HCl)
AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID USE DISORDER
EDENBRIDGE/DEXC
Drug class
Buprenorphine
Buprenorphine is a specific semi-synthetic active drug substance rather than a distinct therapeutic drug class; pharmacologically, it belongs to the opioid partial agonist class. Read more about Buprenorphine
58 drugs in this class 39 manufacturers
Drugs in Buprenorphine
BUPRENORPHINE HCL
AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · PREVENTION OF RELAPSE TO OPIOID DEPENDENCE ·+1
CAMBER PHARMACE
BUPRENORPHINE-NALOXONE (buprenorphine HCl/naloxone HCl)
AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID USE DISORDER
CAMBER PHARMACE
BUPRENORPHINE-NALOXONE (buprenorphine HCl/naloxone HCl)
AGENTS TO TREAT OPIOID (OPIATE) DEPENDENCE · OPIOID USE DISORDER
ASCEND LABORATO
Filter & compare in the drug finder →
Opens the drug finder with Buprenorphine preselected. Add indication or manufacturer filters there.
Buprenorphine is a specific semi-synthetic active drug substance rather than a distinct therapeutic drug class; pharmacologically, it belongs to the opioid partial agonist class.
It exerts its primary therapeutic effect by functioning as a high-affinity partial agonist at mu-opioid receptors and an antagonist at kappa-opioid receptors.
Because this mechanism produces analgesia and suppresses withdrawal symptoms while exhibiting a ceiling effect on respiratory depression and euphoria, it is primarily indicated for the treatment of opioid use disorder as maintenance or induction therapy, as well as for the management of severe acute and chronic pain.
-
fda.gov
Buprenorphine is a specific semi-synthetic active drug substance rather than a distinct therapeutic drug class; pharmacologically, it belongs to the opioid partial agonist class
-
nih.gov
Buprenorphine is a specific semi-synthetic active drug substance rather than a distinct therapeutic drug class; pharmacologically, it belongs to the opioid partial agonist class Because this mechanism produces analgesia and suppresses withdrawal symptoms while exhibiting a ceiling effect on respiratory depression and euphoria, it is primarily indicated for the treatment of opioid use disorder as maintenance or induction therapy, as well as for the management of severe acute and chronic pain
-
drugs.com
It exerts its primary therapeutic effect by functioning as a high-affinity partial agonist at mu-opioid receptors and an antagonist at kappa-opioid receptors Because this mechanism produces analgesia and suppresses withdrawal symptoms while exhibiting a ceiling effect on respiratory depression and euphoria, it is primarily indicated for the treatment of opioid use disorder as maintenance or induction therapy, as well as for the management of severe acute and chronic pain
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.